ResearcherSuzhou Zelgen Biopharmaceuticals Co.,LtdNo recent work listed

Jason Wu

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 9 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 2
Grants: 0
Labs led: 0
Collaborators: 0

Papers, trials and grants by year

2022: 1 trial · 2023: 1 trial

Trials 2

A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours Study chair NCT06237413 ↗
Study of ZGGS18 in Patients With Advanced Solid Tumors Study director NCT05584800 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.